IFP Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$1 | – | 4985 |
|
|
2025
Q1 | $1 | Hold |
3
| – | – | ﹤0.01% | 4292 |
|
|
2024
Q4 | $2 | Buy |
+3
| New | +$2 | ﹤0.01% | 4583 |
|
|
2023
Q1 | – | Sell |
-8
| Closed | -$1K | – | 3983 |
|
|
2022
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 4388 |
|
|
2022
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 4596 |
|
|
2022
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 4371 |
|
|
2022
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 4371 |
|
|
2021
Q4 | – | Sell |
-11,077
| Closed | -$28K | – | 3381 |
|
|
2021
Q3 | $28K | Buy |
11,077
+8,000
| +260% | +$20.2K | ﹤0.01% | 1788 |
|
|
2021
Q2 | $9K | Hold |
3,077
| – | – | ﹤0.01% | 2247 |
|
|
2021
Q1 | $8K | Buy |
3,077
+2,000
| +186% | +$5.2K | ﹤0.01% | 2211 |
|
|
2020
Q4 | $2K | Hold |
1,077
| – | – | ﹤0.01% | 2606 |
|
|
2020
Q3 | $1K | Hold |
1,077
| – | – | ﹤0.01% | 2630 |
|
|
2020
Q2 | $1K | Hold |
1,077
| – | – | ﹤0.01% | 2526 |
|
|
2020
Q1 | $1K | Hold |
1,077
| – | – | ﹤0.01% | 2510 |
|
|
2019
Q4 | $1K | Hold |
1,077
| – | – | ﹤0.01% | 2669 |
|
|
2019
Q3 | $1K | Buy |
+1,077
| New | +$1K | ﹤0.01% | 2869 |
|
|
2019
Q1 | – | Sell |
-15
| Closed | – | – | 2917 |
|
|
2018
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 3672 |
|
|
2017
Q4 | – | Sell |
-34
| Closed | – | – | 3911 |
|
|
2017
Q3 | $0 | Hold |
34
| – | – | ﹤0.01% | 4102 |
|
|
2017
Q2 | $0 | Hold |
34
| – | – | ﹤0.01% | 4116 |
|
|
2017
Q1 | $0 | Hold |
34
| – | – | ﹤0.01% | 4028 |
|
|
2016
Q4 | $0 | Hold |
34
| – | – | ﹤0.01% | 4030 |
|
|
2016
Q3 | $0 | Hold |
34
| – | – | ﹤0.01% | 3951 |
|
|
2016
Q2 | $0 | Buy |
+34
| New | – | ﹤0.01% | 4022 |
|